¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 4ȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦ 4ȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ

±³À°ÁÖÁ¦ : Á¦ 4ȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀμº¼îÅ©¿¬±¸È¸

´ã´çÀÚ : ±èÀºÁø
¿¬¶ôó : 02-3410-6475

À̸ÞÀÏ : kcswg2021@gmail.com

±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ï : ±³¼ö ¹× °³¿øÀÇ 30,000/ Àü°øÀÇ ¹× ±âŸ 20,000ÇöÀåµî·Ï : ±³¼ö ¹× °³¿øÀÇ 40,000/ Àü°øÀÇ ¹× ±âŸ 30,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 09:00~09:20 Pathophysiology and early diagnosis of cardiogenic shock À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 09:20~09:40 How to apply SCAI classification in practice ±è¼Ò¸®(°í´ë¾È¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 09:40~10:00 How to monitor the patient in cardiogenic shock ÀÓ¿ëȯ(Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 10:00~10:20 Critical care ultrasound ÇÏ¿µ·Ï(¼¼ºê¶õ½ºº´¿ø)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 10:20~10:35 Åä·Ð ()

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 10:35~10:45 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 10:45~11:05 Optimal fluid therapy in cardiogenic shock ±è¼öÇö(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 11:05~11:25 Optimal inovasopressor therapy in cardiogenic shock ¹è´ëȯ(ÃæºÏ´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 11:25~11:45 Start, maintenance, and weaning of mechanical ventilator therapy ¹Ú¼ºÈÆ(ÇѸ²´ë¼º½Éº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 11:45~12:05 Renal replacement therapy: when, what, and how ÀÌ°æÈ£(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 12:05~12:20 Åä·Ð ()

½Ä»ç 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 12:20~13:00 ½Ä»ç ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 13:00~13:20 General nursing care for cardiogenic shock È«±â»Ý(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 13:20~13:40 Infection prevention in cardiac ICU Æí¹Ì°æ(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 13:40~14:00 Nutrition for shock patients ¹ÚÄ¡¹Î(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 14:00~14:20 Cardiac rehabilitation in cardiac ICU ÀÌ°æºÀ(°­¿ø´ëÇб³ ¹°¸®Ä¡·áÇаú)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 14:20~14:35 Åä·Ð ()

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 14:35~14:45 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 14:45~15:05 Optimal use of intra-aortic balloon pump °­ÇÊÁ¦(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 15:05~15:25 How to start VA-ECMO: priming, cannulation, and start Á¶¼öÇö (»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 15:25~15:45 How to maintain VA-ECMO: monitoring, medication, and weaning À§Áø (±âõ´ë±æº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 15:45~16:05 How to prevent complications of VA-ECMO ½Å¿ëÈÆ(°í´ë¾È¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ A 16:05~16:25 Central ECMO: indication and maintenance È«Á¤¾Ö(ÆòÃ̼º½Éº´¿ø)

Åä·Ð 05¿ù 18ÀÏ 16:25~16:40 Åä·Ð ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 09:00~09:20 Review of MCS trials: focused on ECLS-SHOCK trial ¼º¼®¿ì(Ãæ³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 09:20~09:40 Critical review of ECPR trials: ARREST, PRAGUE-OHCA, INCEPTION Á¤Àç½Â(°í´ë¾È¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 09:40~10:00 Update from RESCUE-SHOCK trial ÃÖ±âÈ«(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 10:00~10:20 Update from PACE-SHOCK trial ±è¾Æ¶÷(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 10:20~10:35 Åä·Ð ()

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 10:35~10:45 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 10:45~11:05 How to deal with patients in shock and acute ischaemic mitral regurgitation ±èµ¿±â(ÀÎÁ¦´ëÇØ¿î´ë¹éº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 11:05~11:25 Optimal timing of staged revasculariztion in AMI complicated by CS ±è¹Îö (Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 11:25~11:45 Treatment of thrombotic occlusion with giant coronary aneurysm in AMI complicated by CS À±¿µÁø(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 11:45~12:05 Early neurologic assessment in AMI patients with OHCA À¯Á¤¾Ï(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 12:05~12:20 Åä·Ð ()

½Ä»ç 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 12:20~13:00 ½Ä»ç ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 13:00~13:20 Interesting Shock Cases - °è¸í´ëµ¿»êº´¿ø ÀÌÈñÁ¤(°è¸í´ëµ¿»êº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 13:20~13:40 Interesting Shock Cases - Ãæ³²´ëº´¿ø ±èÁö¿¬(Ãæ³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 13:40~14:00 Interesting Shock Cases - ÀÎõ¼¼Á¾º´¿ø ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 14:00~14:20 Interesting Shock Cases - ¼¼ºê¶õ½ºº´¿ø ÀÌ»óÇù(¼¼ºê¶õ½ºº´¿ø)

Åä·Ð 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 14:20~14:35 Åä·Ð ()

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 14:35~14:45 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 14:45~15:05 VA ECMO in cardiogenic shock: patient selection and circuit initiation Á¶¾çÇö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 15:05~15:25 Venting and unloading for patients undergoing VA ECMO: who, why, when and how Á¤Àμ®(Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 15:25~15:45 Advantages of Centrimag over Central ECMO ¼Û½Âȯ (ºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 15:45~16:05 Stadardization and Protocolization of VA ECMO management in Korea ±èÀÎö (°è¸í´ëµ¿»êº´¿ø)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¿ïµå·¡°ï½ÃƼ ÇѶóȦ B 16:05~16:25 ±¹¸³º¸°Ç¿¬±¸¿ø°ú ÇÔ²²ÇÏ´Â ½ÉÀμº¼îÅ© ÀÌÇàÁ¦°í ¿¬±¸ ±ÇÇöö (»ï¼º¼­¿ïº´¿ø)

Åä·Ð 05¿ù 18ÀÏ 16:25~16:40 Åä·Ð ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 4ȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѸ²ÇÁºÎÁ¾ÇÐȸ Á¦9ȸ Ãá°èÇмú´ëȸ ¹× ¿öÅ©¼ó : 2024-05-18
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 5¿ù 17ÀÏ ±Ý¿äÁý´ãȸ(¼Ò¾Æ À½¼º Àå¾Ö¿¡ ´ëÇÑ Á¢±Ù) : 2024-05-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20574 °­¿ø ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - 2024³â Ãá°è½ÉÆ÷Áö¾ö (2ÀÏÂ÷) : 2024-06-08 0 45 2024-04-29
20573 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2024 Kyung Hee Knee Symposium : 2024-06-08 0 58 2024-04-29
20572 ¼­¿ï 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 51 2024-04-29
20571 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ °¨¿°°ü¸®ÀÇ»ç ¿¬¼ö±³À° : 2024-06-08 0 56 2024-04-29
20570 Á¦ÁÖ 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-06-08 0 52 2024-04-29
20569 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ 1Â÷ ½ÉÆ÷Áö¾ö : 2024-06-08 0 53 2024-04-29
20568 °­¿ø ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - 2024³â Ãá°è½ÉÆ÷Áö¾ö (1ÀÏÂ÷) : 2024-06-07 0 52 2024-04-29
20567 ´ëÀü Á¦114Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Á¤±âÇмú´ëȸ : 2024-06-07 0 43 2024-04-29
20566 ´ë±¸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2024-06-04 0 46 2024-04-29
20565 ¼­¿ï Á¦24ȸ ´ëÇÑ°»³â±âÇÐȸ 2024 Ãá°èÇмú´ëȸ : 2024-06-02 0 32 2024-04-29
20564 ¼­¿ï 2024 ´ëÇÑÄ¡¸ÅÇÐȸ Ä¡¸ÅƯº°µî±Þ ÀÇ»ç¼Ò°ß¼­ ÀÛ¼º ±³À° : 2024-06-02 0 48 2024-04-29
20563 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø °³¿ø 5Áֳ⠱â³ä ¿Ü°ú ½ÉÆ÷Áö¾ö ¹× °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-02 0 60 2024-04-29
20562 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-02 0 41 2024-04-29
20561 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ IFFAS 2024 (3ÀÏÂ÷) : 2024-06-01 0 57 2024-04-29
20560 °æ±â 2024 ¼º³²½ÃÀÇ»çȸ »ó¹Ý±â Çмú´ëȸ : 2024-06-01 0 54 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷